// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Acute exacerbation of COPD: A qualitative exploration of the incident symptomatic experience

Bedor Alkhathlan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Impact of a Specialist Breathlessness Group

Samantha Pilsworth - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Lung Cancer

N/A

Evaluation of a new Numerical Rating Scale for quality of life for Dysfunctional Breathing

David Ford - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD

Kirsti J Loughran - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The use of a shortened Multiple Breath Washout in the assessment of airway clearance in patients with COPD

Enya Daynes - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

UK survey of current cough augmentation management in patients with motor neurone disease

Rachel Szczepanski - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry

Arietta Spinou - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient and public involvement (PPI to inform a survey on airways clearance treatments in bronchiectasis

Katherine O'Neill - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Respiratory physiotherapy: Process mapping to target quality improvement and scope areas for future research

Katherine O'Neill - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mechanical insufflation-exsufflation for the prevention and treatment of respiratory complications in acute cervical spinal cord injury: a retrospective analysis

Debbie Hubbard - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic spinal cord injury

N/A

A pilot study investigating the PlayPhysio device and associated app

Laura Lowndes - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Device-based assessment of physical activity after lung cancer surgery

Samantha Harrison - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Identifying heart rate threshold for moderate to vigorous physical activity in children and young people wearing activity trackers

Helen Douglas - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulmonary Rehabilitation (PR in Cheshire and Merseyside (C&M

Samantha Pilsworth - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients

Rachelle Asciak - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Malignant pleural mesothelioma

N/A

Utility of pleural fluid for predictive marker testing in malignant pleural effusion

Jenny Ferguson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gynaecological cancer

N/A

Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro

Rachelle Asciak - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Preliminary Results of the Meso-ORIGINS Feasibility Study

Katie Ferguson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Study of physical activity and sedentary behaviour in patients with malignant pleural effusion undergoing therapeutic interventions: ASPIRE

Radhika Banka - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Computed tomography evidence of lymphangitis associated to malignant pleural effusion: its prevalence and impact on survival

Olalla Castro Añón - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved